1,1,1,1-KestohexoseCAS# 62512-19-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 62512-19-0 | SDF | Download SDF |
PubChem ID | 50938612.0 | Appearance | Powder |
Formula | C36H62O31 | M.Wt | 990.86 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | 1,1,1,1-kestohexaose | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | ||
SMILES | C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)COC3(C(C(C(O3)CO)O)O)COC4(C(C(C(O4)CO)O)O)COC5(C(C(C(O5)CO)O)O)COC6(C(C(C(O6)CO)O)O)CO)O)O)O)O | ||
Standard InChIKey | BWRYDXSZCCQXIF-TWMOFSFSSA-N | ||
Standard InChI | InChI=1S/C36H62O31/c37-1-12-18(44)24(50)25(51)31(61-12)67-36(30(56)23(49)17(6-42)66-36)11-60-35(29(55)22(48)16(5-41)65-35)10-59-34(28(54)21(47)15(4-40)64-34)9-58-33(27(53)20(46)14(3-39)63-33)8-57-32(7-43)26(52)19(45)13(2-38)62-32/h12-31,37-56H,1-11H2/t12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24+,25-,26+,27+,28+,29+,30+,31-,32-,33-,34-,35-,36+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
1,1,1,1-Kestohexose Dilution Calculator
1,1,1,1-Kestohexose Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.0092 mL | 5.0461 mL | 10.0922 mL | 20.1845 mL | 25.2306 mL |
5 mM | 0.2018 mL | 1.0092 mL | 2.0184 mL | 4.0369 mL | 5.0461 mL |
10 mM | 0.1009 mL | 0.5046 mL | 1.0092 mL | 2.0184 mL | 2.5231 mL |
50 mM | 0.0202 mL | 0.1009 mL | 0.2018 mL | 0.4037 mL | 0.5046 mL |
100 mM | 0.0101 mL | 0.0505 mL | 0.1009 mL | 0.2018 mL | 0.2523 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Creatinine
Catalog No.:BCX0629
CAS No.:60-27-5
- Blestriarene A
Catalog No.:BCX0628
CAS No.:126721-53-7
- (+)-Balanophonin
Catalog No.:BCX0627
CAS No.:215319-47-4
- γ-sanshool
Catalog No.:BCX0626
CAS No.:78886-65-4
- Yibeinoside A
Catalog No.:BCX0625
CAS No.:98985-24-1
- 4-Methoxy-1,2-benzenediol
Catalog No.:BCX0624
CAS No.:3934-97-2
- 1-Deoxyforskolin
Catalog No.:BCX0623
CAS No.:72963-77-0
- 2,3-Dimethoxybenzoic acid
Catalog No.:BCX0622
CAS No.:1521-38-6
- 6-Deoxy-D-glucose
Catalog No.:BCX0621
CAS No.:7658-08-4
- trans-4-Methoxycinnamic acid
Catalog No.:BCX0620
CAS No.:943-89-5
- Saikogenin F
Catalog No.:BCX0619
CAS No.:14356-59-3
- 11-Oxo-Alpha-Amyrin
Catalog No.:BCX0618
CAS No.:2118-90-3
- Uric acid
Catalog No.:BCX0631
CAS No.:69-93-2
- Monoethyl fumaric acid
Catalog No.:BCX0632
CAS No.:2459-05-4
- N-Methyl-1-deoxynojirimycin
Catalog No.:BCX0633
CAS No.:69567-10-8
- Ocimene
Catalog No.:BCX0634
CAS No.:13877-91-3
- Manzamine A
Catalog No.:BCX0635
CAS No.:104196-68-1
- Crocetin methylester
Catalog No.:BCX0636
CAS No.:25368-09-6
- Lucidin Omega-Methyl Ether
Catalog No.:BCX0637
CAS No.:79560-36-4
- Schiarisanrin A
Catalog No.:BCX0638
CAS No.:130252-41-4
- Palmitoleic acid methyl ester
Catalog No.:BCX0639
CAS No.:1120-25-8
- Gymnoside IX
Catalog No.:BCX0640
CAS No.:898827-00-4
- 2-O-β-D-Glucopyranosyl-L-ascorbic acid
Catalog No.:BCX0641
CAS No.:562043-82-7
- Isokadsuranin
Catalog No.:BCX0642
CAS No.:82467-52-5
Isolation, phytochemistry, characterization, biological activity, and application of Morinda officinalis How oligosaccharide: a review.[Pubmed:37991722]
J Pharm Pharmacol. 2023 Nov 22:rgad096.
Morinda officinalis How oligosaccharide (MOO) stands as one of the principal active constituents of M. officinalis How, widely employed in traditional Chinese medicine. The methods for MOO extraction predominantly encompass hot water extraction, ethanol extraction, ultrasonic-assisted extraction, and microwave-assisted extraction. Distinct extraction techniques yield varying MOO quantities. MOO encompasses a diversity of oligosaccharides, including bajijiasu, sucrose, 1-kestose, nystose, mannose, 1F-fructofuranosylnystose, 1,1,1,1-Kestohexose, fructoheptasaccharide, inulin-type hexasaccharide, inulin-type heptasaccharide, inulotriose, inulotetraose, inulopentaose, and mannose. MOO exhibits a wide spectrum of biological activities, exerting specific effects on the nervous system, cardiovascular system, motor system, reproductive system, and immune system. It demonstrates antidepressant properties, offers potential in mitigating Alzheimer's disease, stimulates angiogenesis, and possesses anti-osteoporotic and other pharmacological effects. Clinically, when combined with various antidepressants, MOO exhibits specific therapeutic efficacy across multiple forms of depression. As a naturally occurring plant oligosaccharide, MOO holds diverse pharmaceutical applications. This article conducts a review of the latest extraction and purification methodologies, structural characterization analysis, biological activity assessment, and clinical applications of MOO. Such a comprehensive analysis yields innovative insights for advancing the research and application of MOO in the future.
Fermentative Production of Fructo-Oligosaccharides Using Aureobasidium pullulans: Effect of Dissolved Oxygen Concentration and Fermentation Mode.[Pubmed:34202788]
Molecules. 2021 Jun 24;26(13):3867.
Fructo-oligosaccharides (FOS) are prebiotics with numerous health benefits. So far, the dissolved oxygen (DO) concentration control strategy for fermentative production of FOS is still unknown. In order to improve FOS production, the effects of DO concentration and fermentation mode on FOS using Aureobasidium pullulans were investigated in this study. The greatest FOS production (123.2 +/- 6.2 g/L), with a yield of 61.6% +/- 3.0% (g FOS/g sucrose), was obtained in batch culture under high DO concentration. Furthermore, repeated-batch culture revealed that enzyme production and FOS production were not closely associated with cell growth. By keeping the DO concentration above 5% in the repeated-batch culture, a maximum FOS concentration of 548.3 +/- 37.4 g/L and yield of 68.6% +/- 2.6% (g FOS/g sucrose) were obtained, which were 3.45% and 11.4% times higher than those obtained in the batch culture without DO control, respectively. Additionally, the ratios of 1-fructofuranosyl nystose (GF4) and 1,1,1,1-Kestohexose (GF5) were 33.8% and 23.2%, respectively, in the product of repeated-batch culture, but these compounds were not detected in batch culture. Thus, it can be concluded that the DO concentration affects not only the yield of FOS but also the composition of FOS with different degrees of polymerization, which is the key factor in the fermentative production of FOS with a high polymerization degree.